Good news follows bad rumour for Exubera
Drug delivery company Nektar Therapeutics has bounced back from a recent share slump after reporting encouraging new data supporting the safety of its inhaled insulin product Exubera.
Drug delivery company Nektar Therapeutics has bounced back from a recent share slump after reporting encouraging new data supporting the safety of its inhaled insulin product Exubera.
Lloyd's Register Serentec has formed a new practice group to provide process analytical technology (PAT) services to pharmaceutical manufacturing clients worldwide.
Nestec of Switzerland, a subsidiary of food giant Nestle, has been awarded a US patent on a new way of producing the whey protein glycomacropeptide (GMP) that could open up its use as an ingredient in pharmaceuticals, dental compositions and foods.
Separation and filtration specialist Millipore has launched an automated system for the rapid detection, response and resolution of microbial contamination in manufacturing processes.